Articles
Cases
News
Issues
CME / CE
Podcasts
Blog
Student Scan
Resources
SUBSCRIBE
MOST RECENT
Telix to Acquire ITM in $1.65 Billion Radiopharmaceutical Merger
ASTRO Unveils Clinical Guideline for Radiation Therapy in Bladder Cancer
2026 ASTRO Annual Meeting to Highlight Innovations in Radiation Oncology
Lantheus Secures FDA Approval for BRAVNETSA, Expanding Treatment Options for GEP-NETs
FDA Approves Telix’s Pixclara for Glioma PET Imaging
New ASTRO Guideline Supports Bladder-Preserving Radiation Therapy for Select Patients
Novel Therapeutic Isotopes Boost Nuclear Medicine Toolbox
Mayo Clinic Develops Innovative Minibeam Therapy for Resistant Cancers
Advancements in Radiotherapy for Oligometastatic Pancreatic Cancer
New Approaches in Glioma Treatment: Focusing on Microscopic Tumor Spread
December 2021
Vol 10 • Issue 4
Full PDF
Digital Edition
Review Article
SBRT vs SABR: Does Terminology Differentiate Treatment Intent in Metastatic Cancer?
Editorial
COVID-19 Continued: Successes, Setbacks and Effects on Radiation Oncology
Review Article
The Economic Impact of the COVID-19 Pandemic on Radiation Oncology Practice
Review Article
Formalized Mentorship in Radiation Oncology in the COVID Era: American College of Radiation Oncology Experience
Technology Trends
ASTRO 2021 Exhibits Highlight Personalized Adaptive Therapy, Workflow Efficiency
Case Report
Breast Cancer
Radiation Recall After the COVID-19 Vaccine: Two Cases and a Review of the Literature
Case Report
Head & Neck Cancer
Delayed Radiation-Therapy-Induced Cerebral Demyelination
Case Report
Lung/Thoracic Cancer
High-Field MR-Guided Radiation Therapy for Oligometastatic Central Lung Cancer: Current State and Future Opportunities
Editorial
Critical Steps During Residency: Advocating for Our Future
Stereotactic Body Radiation Therapy (SBRT) vs Stereotactic Ablative Radiation Therapy (SABR): Does Terminology Differentiate Treatment Intent in Metastatic Cancer?
.